Extended IV DMT put one of the earliest human participants into a prolonged psychedelic state and raised questions about duration, control, and research use

Extended IV DMT kept one of the earliest known human participants in a sustained psychedelic state far longer than a typical smoked or injected DMT experience. The subject was reportedly the 41st person ever to receive the method, placing the account in the early history of attempts to prolong and control DMT's unusually brief effects. The core focus is continuous intravenous administration as a way to move DMT from a short, explosive experience into an extended and more experimentally manageable altered state. That changes the practical and scientific stakes by allowing researchers to study onset, maintenance, and termination with greater precision than single-bolus dosing. Prolonged delivery also raises wider questions about how consciousness is shaped by dose control, how tolerable and safe longer exposures may be, and how such protocols could influence future psychedelic research design. The subject sits at the intersection of psychopharmacology, experimental method, and the effort to make intense nonordinary states more measurable.